$ERAS stock has now risen 8% today, according to our price data from Polygon. There has been approximately $60,517,487 of trading volume.
It has been the 877th most-searched ticker on Quiver Quantitative over the last day, out of 11,246 total tickers searched.
Here is what we see in our data on $ERAS (you can track the company live on Quiver's $ERAS stock page):
$ERAS Insider Trading Activity
$ERAS insiders have traded $ERAS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ERAS stock by insiders over the last 6 months:
- EBUN GARNER (General Counsel & Corp. Sec.) sold 120,000 shares for an estimated $670,812
- SHANNON MORRIS (Chief Medical Officer) sold 20,000 shares for an estimated $300,760
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ERAS Hedge Fund Activity
We have seen 73 institutional investors add shares of $ERAS stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 15,445,081 shares (-76.3%) from their portfolio in Q4 2025, for an estimated $57,455,701
- LOGOS GLOBAL MANAGEMENT LP removed 2,150,000 shares (-14.2%) from their portfolio in Q4 2025, for an estimated $7,998,000
- STATE STREET CORP added 2,145,386 shares (+53.2%) to their portfolio in Q4 2025, for an estimated $7,980,835
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 1,490,967 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,546,397
- SIO CAPITAL MANAGEMENT, LLC removed 1,369,748 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,095,462
- PFM HEALTH SCIENCES, LP removed 1,072,224 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,337,448
- ROCK SPRINGS CAPITAL MANAGEMENT LP added 951,710 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,540,361
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ERAS Analyst Ratings
Wall Street analysts have issued reports on $ERAS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 11/14/2025
- Stifel issued a "Buy" rating on 10/16/2025
To track analyst ratings and price targets for $ERAS, check out Quiver Quantitative's $ERAS forecast page.
$ERAS Price Targets
Multiple analysts have issued price targets for $ERAS recently. We have seen 9 analysts offer price targets for $ERAS in the last 6 months, with a median target of $19.0.
Here are some recent targets:
- Anupam Rama from JP Morgan set a target price of $25.0 on 03/18/2026
- Michael Schmidt from Guggenheim set a target price of $20.0 on 03/16/2026
- Andres Y. Maldonado from HC Wainwright & Co. set a target price of $20.0 on 03/13/2026
- Joseph Catanzaro from Mizuho set a target price of $19.0 on 03/13/2026
- Kelsey Goodwin from Piper Sandler set a target price of $18.0 on 03/13/2026
- Kaveri Pohlman from Clear Street set a target price of $20.0 on 03/06/2026
- Laura Prendergast from Stifel set a target price of $4.0 on 10/16/2025
You can track data on $ERAS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
